Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Viusid and Asbrip in Hospitalized Patients With Mild and Moderate COVID-19

NCT04701502 is registered in ClinicalTrials.gov with Catalysis SL as lead sponsor.

NCT NCT04701502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04701502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Viusid and Asbrip in Hospitalized Patients With Mild and Moderate COVID-19
Lead sponsor
Catalysis SL
Phase
Phase 2
Overall status
Completed
Start date
November 9, 2020
Completion date
February 15, 2021
Enrollment
60 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

antiseptic, covid19, immune system, immunomodulator, respiratory disease, supportive care